Company Encyclopedia
View More
name
SCWorx
WORX.US
SCWorx Corp., together with its subsidiaries, provides data content and services related to the repair, normalization and interoperability of information for healthcare providers in the United States. The company develops and markets healthcare information technology solutions and associated services that improve healthcare processes and information flow within hospitals and other healthcare facilities. Its software modules perform separate functions, such as virtualized item master file repair, expansion, and automation; electronic medical record management; charge description master management; contract management; request for proposal automation; integration of acquired businesses; rebate management; big data analytics model; and data integration and warehousing. The company sells its solutions and services to hospitals and health systems through a direct sales force, and distribution and reseller partnerships.
70.39 B
WORX.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care TechnologyIndustry
Industry Ranking29/44
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-74.23%E
    • Profit Margin-139.71%E
    • Gross Margin35.69%C
  • Growth ScoreD
    • Revenue YoY-13.64%E
    • Net Profit YoY-10.83%D
    • Total Assets YoY10.02%B
    • Net Assets YoY33.72%A
  • Cash ScoreD
    • Cash Flow Margin-71.58%D
    • OCF YoY-13.64%E
  • Operating ScoreC
    • Turnover0.41C
  • Debt ScoreA
    • Gearing Ratio16.42%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    SCWorx | 10-Q: FY2025 Q3 Revenue: USD 705.8 K

    LB filings·
    US
    WORX
    -3.05%
    LB filings·
    US
    WORX
    -3.05%

    SCWorx Granted 180-Day Nasdaq Extension to Regain $1 Minimum Bid Price Compliance

    SCWorx Corporation has received a 180-day extension from Nasdaq to regain compliance with the minimum $1.00 per share bid price requirement for continued listing on the Nasdaq Capital Market. The company must achieve a closing bid price of at least $1.00 for 10 consecutive business days by April 6, 2026. If compliance is not met, SCWorx plans to implement a reverse stock split, as previously approved by shareholders. The stock will continue trading under the symbol "WORX" during this period.

    Reuters·
    US
    WORX
    -3.05%
    Reuters·
    US
    WORX
    -3.05%

    Pre-market hot trades in US stocks: SCWorx pre-market down 8.52%

    SCWorx pre-market down 8.52%; Trilogy Mets pre-market up 169.86%; Galecto pre-market up 140.97%; Bluejay Diagnostics pre-market up 80.00%

    Tracking Unusual Activity·
    US
    WORX
    -3.05%
    Tracking Unusual Activity·
    US
    WORX
    -3.05%

    SCWorx shares are trading higher after the company announced it renewed a 3-year healthcare partner agreement with $1.69 million in expected revenue.

    benzinga_article·
    US
    WORX
    -3.05%
    benzinga_article·
    US
    WORX
    -3.05%

    SCWorx renews healthcare partner agreement for 3 years with 113% contract increase to $1.69M total revenue.

    On October 6, 2025, SCWorx Corp, a prominent healthcare data management solutions provider listed on NASDAQ under symbol WORX, revealed a contract renewal with a long-standing healthcare partner for an additional three years. The customer, an aggregate purchasing group collaborating with SCWorx for eight years, has opted to extend their agreement, resulting in a substantial 113% growth in value from the previous term. The new contract is anticipated to generate total revenue of around $1,692,000 over the three-year period.

    Unusual Whales·
    US
    WORX
    -3.05%
    Unusual Whales·
    US
    WORX
    -3.05%
    © 2025 Longbridge｜Disclaimer